Takeda Pharmaceutical Company Limited
TAK
$14.16
$0.443.21%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.43B | 2.57B | 3.14B | 6.00B | 5.00B |
| Total Receivables | 4.71B | 4.84B | 4.68B | 5.03B | 4.80B |
| Inventory | 8.60B | 8.13B | 7.93B | 8.42B | 7.94B |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.68B | 1.29B | 1.77B | 1.87B | 1.58B |
| Total Current Assets | 17.42B | 16.84B | 17.52B | 21.32B | 19.32B |
|
|
|||||
| Total Current Assets | 17.42B | 16.84B | 17.52B | 21.32B | 19.32B |
| Net Property, Plant & Equipment | 13.56B | 13.14B | 12.83B | 13.18B | 12.96B |
| Long-term Investments | 36.71B | 35.56B | 35.12B | 36.02B | 35.64B |
| Goodwill | 36.71B | 35.56B | 35.12B | 36.02B | 35.64B |
| Total Other Intangibles | 23.72B | 24.25B | 25.14B | 26.32B | 27.14B |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 5.59B | 5.29B | 5.39B | 4.78B | 5.27B |
| Total Assets | 97.07B | 95.15B | 96.09B | 101.72B | 100.88B |
|
|
|||||
| Total Accounts Payable | 2.92B | 2.06B | 2.93B | 2.89B | 2.91B |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | 2.05B | 2.30B | -- | -- | 1.86B |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 520.14M | 1.79B | 861.64M | 4.36B | 862.48M |
| Total Finance Division Other Current Liabilities | 9.55B | 10.58B | 9.56B | 9.42B | 9.68B |
| Total Other Current Liabilities | 9.55B | 10.58B | 9.56B | 9.42B | 9.68B |
| Total Current Liabilities | 15.04B | 16.74B | 13.34B | 16.66B | 15.32B |
|
|
|||||
| Total Current Liabilities | 15.04B | 16.74B | 13.34B | 16.66B | 15.32B |
| Long-Term Debt | 28.66B | 26.49B | 29.92B | 30.90B | 31.34B |
| Short-term Debt | 2.05B | 2.30B | -- | -- | 1.86B |
| Capital Leases | 3.71B | 3.40B | 3.76B | 3.90B | 3.83B |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.07B | 2.21B | 1.87B | 1.95B | 1.89B |
| Total Liabilities | 49.48B | 48.83B | 48.90B | 53.41B | 52.39B |
|
|
|||||
| Common Stock & APIC | 24.16B | 23.17B | 21.95B | 23.96B | 21.36B |
| Retained Earnings | 8.02B | 7.93B | 8.21B | 9.99B | 8.32B |
| Treasury Stock & Other | 15.41B | 15.21B | 17.02B | 14.35B | 18.80B |
| Total Common Equity | 47.58B | 46.31B | 47.18B | 48.31B | 48.48B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 47.58B | 46.31B | 47.18B | 48.31B | 48.48B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 6.38M | 5.98M | 5.83M | 5.88M | 5.07M |
| Total Equity | 47.59B | 46.32B | 47.19B | 48.31B | 48.48B |
|
|
|||||